Oramed PharmaceuticalsORMP
13F holders, Q1 2024 (March 31)51holders
2famous investors
$2.92avg. 13F price*
At the end of Q1 2024, 51 institutions reported holding Oramed Pharmaceuticals Inc. (ORMP) in their 13F filings. The largest holders were Murchinson Ltd. ($4.0M), BML Capital Management, LLC ($2.5M) and Boothbay Fund Management, LLC ($2.0M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Oramed Pharmaceuticals Inc.
- CUSIP
- 68403P203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $374K |
| Exits | 13 | $239K |
Ownership 51 holders
| Murchinson Ltd. | 0.46% | Add +31.4% | 1,379,495 | $4.0M |
| BML Capital Management, LLC | 1.65% | Reduce -33.1% | 844,496 | $2.5M |
| Boothbay Fund Management, LLC | 0.06% | Add +31.4% | 689,749 | $2.0M |
| Susquehanna International Group, LLP | 0.00% | Add +650.1% | 344,438 | $1.0M |
| Rathbones Group PLC | 0.00% | No change | 289,803 | $846K |
| Bank of America Corp. | 0.00% | Add +5.8% | 287,052 | $838K |
| Two Sigma Advisers, LP | 0.00% | Reduce -7.1% | 263,500 | $769K |
| Two Sigma Investments, LP | 0.00% | Reduce -14.5% | 134,454 | $393K |
| Renaissance Technologies | 0.00% | Reduce -64.2% | 122,100 | $357K |
| BlackRock Inc. | 0.00% | Add +1.8% | 89,295 | $261K |
| Squarepoint Ops LLC | 0.00% | Reduce -24.0% | 89,125 | $260K |
| Qube Research & Technologies Ltd | 0.00% | Add +1.9% | 88,196 | $258K |
| Jane Street Group, LLC | 0.00% | Reduce -9.5% | 86,424 | $252K |
| D. E. Shaw & Co. | 0.00% | Add +19.4% | 70,502 | $206K |
| State Street Corp. | 0.00% | Add +0.3% | 58,132 | $170K |
| LPL Financial LLC | 0.00% | Add +5.6% | 45,601 | $133K |
| Morgan Stanley | 0.00% | Reduce -30.4% | 44,709 | $131K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 26,200 | $77K |
| Geode Capital Management, LLC | 0.00% | No change | 25,455 | $74K |
| Virtu Financial LLC | 0.01% | New | 23,165 | $68K |
| Dimensional Fund Advisors LP | 0.00% | New | 20,696 | $60K |
| American Century Companies Inc. | 0.00% | Add +1.6% | 19,591 | $57K |
| Group One Trading LLC | 0.00% | Add +82.7% | 18,995 | $55K |
| Savvy Advisors, Inc. | 0.03% | New | 18,810 | $55K |
| Assenagon Asset Management S.A. | 0.00% | New | 18,659 | $54K |
| Sage Capital Management, LLC | 0.03% | New | 16,750 | $49K |
| Barclays PLC | 0.00% | No change | 13,239 | $39K |
| N.E.W. Advisory Services LLC | 0.00% | No change | 12,960 | $38K |
| Altshuler Shaham Ltd | 0.00% | Reduce -6.4% | 12,020 | $35K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Reduce -4.2% | 11,400 | $33K |
| TrinityBridge Ltd | 0.00% | No change | 11,400 | $33K |
| JPMorgan Chase & Co. | 0.00% | Reduce -61.0% | 11,210 | $33K |
| Mariner, LLC | 0.00% | New | 10,544 | $31K |
| Glass Jacobson Investment Advisors llc | 0.01% | No change | 10,540 | $31K |
| Journey Strategic Wealth LLC | 0.00% | New | 10,448 | $31K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 8,826 | $26K |
| Wells Fargo & Company | 0.00% | Add +66.7% | 7,501 | $22K |
| Huntington National Bank | 0.00% | No change | 5,002 | $15K |
| UBS Group AG | 0.00% | Reduce -8.2% | 4,649 | $14K |
| Osaic Holdings, Inc. | 0.00% | Reduce -44.5% | 4,649 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +354.3% | 2,662 | $8K |
| McIlrath & Eck, LLC | 0.00% | No change | 2,000 | $6K |
| Rhumbline Advisers | 0.00% | No change | 1,830 | $5K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,575 | $5K |
| City Holding Co. | 0.00% | No change | 1,070 | $3K |
| Concourse Financial Group Securities, Inc. | 0.00% | No change | 1,000 | $3K |
| NFSG Corp | 0.00% | No change | 657 | $2K |
| IFP Advisors, Inc | 0.00% | Reduce -66.7% | 500 | $1K |
| Tyler-Stone Wealth Management | 0.00% | No change | 300 | $876 |
| Beacon Capital Management, LLC | 0.00% | No change | 219 | $639 |
| Global Retirement Partners, LLC | 0.00% | No change | 100 | $292 |
"% of holder's portfolio" is ORMP's weight in each manager's 13F, not the share of Oramed Pharmaceuticals Inc. the manager owns.